Pragna Pharma Private Limited

Pragna Pharma Private Limited - chemicals and materials in Dahej, Gujarat, India. FY 2026 financials & compliance.
CIN U24110GJ2012PTC068475 Incorporated 04 January 2012 ROC Ahmedabad HQ Dahej, Gujarat, India
Active Private Limited Company chemicals and materials MSME · Medium
Revenue · FY 2025
₹148.79 Cr
▲ 72% YoY
Net profit · FY 2025
₹23.54 Cr
Net margin 15.8%
EBITDA · FY 2025
₹37.73 Cr
EBITDA margin 25.4%
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹3 Cr
Issued & subscribed
Open charges
₹25.07 Cr
Satisfied ₹11.98 Cr
Company age
14 yrs
Est. 2012
Employees · EPFO
264
Provident fund records

About Pragna Pharma Private Limited

Data last updated:

Pragna Pharma Private Limited is a private limited company based in Dahej, Gujarat, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 04 January 2012 and has been in existence for over 14 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24110GJ2012PTC068475. Its GSTIN is 24AAQCS8682K1ZH (Gujarat).

The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹3 Cr. It was formerly known as Shree Avani Chem Industries Private Limited. It is led by directors including Rakeshkumar V Kothiya and Dipakkumar Shankarlal Patel.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No D – 2/Ch/224 GIDC – 2 Tal – Vagra, Dahej, Gujarat, India – 392130.

As per the financials filed for FY 2025, the company reported a revenue of ₹148.79 Cr, a growth of 72% compared to the previous year. For the same year it recorded a net profit of ₹23.54 Cr (net margin 15.8%) and EBITDA of ₹37.73 Cr (EBITDA margin 25.4%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 25% over five years.

The company has about 264 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹25.07 Cr and satisfied charges of ₹11.98 Cr on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it. The company has 6 deals on record (3 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹2.41 Cr; the latest was in September 2023. Its 6 peer companies in the Chemicals industry (Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 4 smaller; the largest is Suntek Plasticizer Private Limited with revenue of ₹150.61 Cr.

Pragna Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-06-0002031). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pragnachemicalindustries.com.

Company details

CIN U24110GJ2012PTC068475
Registration Number 068475
Incorporation Date 04 January 2012
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-GJ-06-0002031

Recognitions & Rankings of Pragna Pharma

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-GJ-06-0002031

Contact details

Pragna Pharma Private Limited's registered office is in Dahej, Gujarat. Its website is pragnachemicalindustries.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Plot No D – 2/Ch/224 GIDC – 2 Tal – Vagra, Dahej, Gujarat, India – 392130
  • Industry
    Chemicals and Materials, Industrial Chemicals

To see the full contact details of Pragna Pharma Private Limited, buy the company report.

Comprehensive company report
Pragna Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Pragna Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Pragna Pharma Private Limited, buy the company report.

Financials of Pragna Pharma Private Limited

FY 2024 filings available

Pragna Pharma Private Limited reported revenue of ₹148.79 Cr (up 72% YoY) for FY 2025.

Revenue · FY 2025
₹148.79 Cr ▲ 72%
Net profit · FY 2025
₹23.54 Cr margin 15.8%
EBITDA · FY 2025
₹37.73 Cr margin 25.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 72%
3 years · compounded
▲ 22%
5 years · compounded
▲ 25%
EBITDA CAGR growth
1 year
▲ 344%
3 years · compounded
▲ 8%
5 years · compounded
▲ 19%

Revenue has grown at a compounded annual rate (CAGR) of 25% over five years, including 72% growth in the latest year. EBITDA rose 344% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹37.73 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹23.54 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin25.4%
Net Profit Margin15.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Pragna Pharma Private Limited, buy the company report.

Board of directors of Pragna Pharma Private Limited

Pragna Pharma has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rakeshkumar V KothiyaDirector01 Jul 20215 Years 4 MonthsCurrent
Dipakkumar Shankarlal PatelDirector01 Jul 20215 Years 4 MonthsCurrent
Jigneshkumar Kalidas PatelDirector01 Jul 20215 Years 4 MonthsCurrent

Peer comparison

Pragna Pharma Private Limited is compared with the 6 companies closest to it by revenue in the Chemicals industry (Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Suntek Plasticizer Private Limited₹150.61 Cr (FY 2025)15.0%Delhi, India
Pandian Chemicals Limited₹148.88 Cr (FY 2025)-6.0%Madurai Dt, Tamil Nadu, India
Pragna Pharma Private Limitedthis company₹148.79 Cr (FY 2025)₹23.54 Cr15.8%72.0%264Dahej, Gujarat, India
Valtris Specialty Chemicals India Private Limited₹146.28 Cr (FY 2025)-2.0%Mumbai, Maharashtra, India
Makwell Organics Private Limited₹146.22 Cr (FY 2025)15.0%Mumbai, Maharashtra, India
JBLD International Private Limited₹144.62 Cr (FY 2025)25.0%Delhi, India
Zavenir Daubert India Private Limited₹139.84 Cr (FY 2025)1.0%New Delhi, Delhi, India

To see the full peer comparison of Pragna Pharma Private Limited, buy the company report.

Auditor

Pragna Pharma Private Limited is audited by RAYS & ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
RAYS & ASSOCIATESFY 2023132846W

Shareholding

The shareholding of Pragna Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Pragna Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹25.07 Cr
Satisfied charges
₹11.98 Cr
Breakdown by lending institutions
Others₹25.00 Cr
Hdfc Bank Limited₹0.07 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
11 Sep 2024100971917Hdfc Bank Limited₹6.5 LakhOpen
01 May 2024100949778Others₹10 CrOpen
01 May 2024100949825Others₹15 CrOpen
18 Jan 2021100423135Hdfc Bank Limited₹3.99 CrSatisfied
02 Jun 2018100182591Hdfc Bank Limited₹7.99 CrSatisfied

To see the full charge records of Pragna Pharma Private Limited, buy the company report.

Total charge records: 5 View all charges

Deals & funding

Pragna Pharma Private Limited has 6 deals on record (3 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹2.41 Cr; the latest was in September 2023.

Total deals
6
Secondary share transfers
3
Funding rounds
2
Rights issue
1
Disclosed funding
₹2.41 Cr

Deals on record (5 of 6)

WhenDealAmountParties
Sep 2023Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Feb 2022Secondary share transferUndisclosedBuyer: 4 individuals
Seller: 4 individuals
Dec 2021Rights issue₹57.9 LakhInvestors: 3 individuals
May 2021Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Feb 2018Funding round₹1.92 CrInvestors: 4 individuals

To see the full deal history of Pragna Pharma Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Pragna Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Pragna Pharma Private Limited has a workforce of 264 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
264
Active EPFO establishments
1
Employee growth
1.9%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27264
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19

To see the full employee and EPFO history of Pragna Pharma Private Limited, buy the company report.

GST

Pragna Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AAQCS8682K1ZHGujaratActive01 Jul 2017

To see the full GST registrations and return filing status of Pragna Pharma Private Limited, buy the company report.

Recent activity

Pragna Pharma Private Limited has 8 board changes on record since 2020: 3 appointments and 5 cessations. The latest: Maheshkumar Jivanlal Patel ceased to be Director on 02 Sep 2022.

AGM
Pragna Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.07 Cr with Charge ID 100971917 was registered on 11 Sep 2024.
Charges
A charge registered on 18 Jan 2021 via Charge ID 100423135 with Hdfc Bank Limited was fully satisfied on 05 Sep 2024.
Charges
A charge registered on 02 Jun 2018 via Charge ID 100182591 with Hdfc Bank Limited was fully satisfied on 05 Sep 2024.
Charges
A charge with Others of Rs. 10.00 Cr registered on 01 May 2024 with Charge ID 100949778 was modified on 14 Aug 2024.
Charges
A charge with Others of Rs. 15.00 Cr registered on 01 May 2024 with Charge ID 100949825 was modified on 14 Aug 2024.
Charges
A charge with Hdfc Bank Limited of Rs. 3.99 Cr registered on 18 Jan 2021 with Charge ID 100423135 was modified on 14 May 2024.
Charges
A charge with Others amounted to Rs. 10.00 Cr with Charge ID 100949778 was registered on 01 May 2024.
Charges
A charge with Others amounted to Rs. 15.00 Cr with Charge ID 100949825 was registered on 01 May 2024.
Filing
Pragna Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
Charges
A charge with Hdfc Bank Limited of Rs. 7.99 Cr registered on 02 Jun 2018 with Charge ID 100182591 was modified on 30 Jan 2024.
Ceased
Maheshkumar Jivanlal Patel ceased to be Director.

10 earlier events are in the company report.

Frequently asked questions

Pragna Pharma is an active private limited company based in Dahej, Gujarat, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 04 January 2012 (14+ years old) and is registered under CIN U24110GJ2012PTC068475.

Pragna Pharma has 3 current directors:

The latest financial statements of Pragna Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Pragna Pharma is 24AAQCS8682K1ZH, registered in Gujarat.

The CIN (Corporate Identification Number) of Pragna Pharma is U24110GJ2012PTC068475. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Pragna Pharma has 2 court cases on record: 1 filed by the company and 1 filed against it.

Pragna Pharma was incorporated on 04 January 2012, making it 14+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Pragna Pharma has 6 deals on record (3 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹2.41 Cr; the latest was in September 2023.

The peers of Pragna Pharma by revenue are Suntek Plasticizer Private Limited, Pandian Chemicals Limited, Valtris Specialty Chemicals India Private Limited, Makwell Organics Private Limited, JBLD International Private Limited and 1 more, all in the Chemicals industry (Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Maheshkumar Jivanlal Patel ceased to be Director on 02 Sep 2022. Urmilaben Maheshbhai Patel ceased to be Director on 02 Sep 2022. Dipakkumar Shankarlal Patel ceased to be Additional Director on 30 Nov 2021. Pragna Pharma has 8 board changes on record in total.

Yes, Pragna Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-GJ-06-0002031).